Cardiomyopathy Trial, Recruiting NCT07689331 Sponsor: Semmelweis University Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT07689331
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with systemic amyloidosis (a disease where abnormal proteins build up in organs and tissues)
  • People who are 18 years of age or older at the time of joining the trial
  • People whose treating doctor has given consent for their participation
  • People for whom medical history records are available and accessible

Who may not be able to join:

  • People who have not signed an informed consent form agreeing to take part in the prospective part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Zoltan Pozsonyi, MD, PhD, Department of Internal Medicine and Hematology, Semmelweis University

Phone: +36208250944

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Semmelweis University
Registry
ClinicalTrials.gov
Start date
8 March 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Sex of Participants at Diagnosis; Age at Diagnosis; Place of Residence at Diagnosis (Postal Code Level); Treating Institution at Diagnosis; Systemic Amyloidosis Subtype at Diagnosis; Date of Symptom Onset; Date of Systemic Amyloidosis Diagnosis; Time from Symptom Onset to Systemic Amyloidosis Diagnosis (Days); Category of Presenting Symptom Leading to Systemic Amyloidosis Diagnosis; Organ Involvement at Diagnosis; Biopsy Performed During Diagnostic Workup; Bone Scintigraphy Performed During Diagnostic Workup; Cardiac MRI Performed During Diagnostic Workup; Carpal Tunnel Syndrome Present at Dia...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov